Cargando…
Progranulin autoantibodies in systemic sclerosis and autoimmune connective tissue disorders: A preliminary study
OBJECTIVE: The present study aimed to investigate progranulin autoantibodies in systemic sclerosis and autoimmune connective tissue disorders. Progranulin is a physiologic tumor necrosis factor (TNF) antagonist. Progranulin antibodies decrease progranulin levels. METHODS: Serum samples of 123 patien...
Autores principales: | Klemm, Philipp, Assmann, Gunter, Preuss, Klaus‐Dieter, Fadle, Natalie, Regitz, Evi, Martin, Thierry, Pfreundschuh, Michael, Thurner, Lorenz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6842819/ https://www.ncbi.nlm.nih.gov/pubmed/31502765 http://dx.doi.org/10.1002/iid3.270 |
Ejemplares similares
-
Progranulin antibodies entertain a proinflammatory environment in a subgroup of patients with psoriatic arthritis
por: Thurner, Lorenz, et al.
Publicado: (2013) -
Integration of the B-Cell Receptor Antigen Neurabin-I/SAMD14 Into an Antibody Format as New Therapeutic Approach for the Treatment of Primary CNS Lymphoma
por: Bewarder, Moritz, et al.
Publicado: (2020) -
Autoantibodies against SUMO1-DHX35 in long-COVID
por: Thurner, Lorenz, et al.
Publicado: (2022) -
Ars2‐containing bispecific, Fab‐ and IgG1‐format BAR‐bodies to target DLBCL cells
por: Kiefer, Maximilian, et al.
Publicado: (2022) -
The B-cell Receptor Autoantigen LRPAP1 Can Replace Variable Antibody Regions to Target Mantle Cell Lymphoma Cells
por: Bewarder, Moritz, et al.
Publicado: (2021)